Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-492,173
Closed -$2.28M 97
2018
Q2
$2.28M Buy
492,173
+12,400
+3% +$72.8K 0.23% 87
2018
Q1
$3.49M Buy
479,773
+131,700
+38% +$906K 0.37% 82
2017
Q4
$2.25M Hold
348,073
0.25% 88
2017
Q3
$2.29M Buy
348,073
+46,502
+15% +$288K 0.27% 86
2017
Q2
$1.66M Sell
301,571
-12,339
-4% -$70.4K 0.22% 82
2017
Q1
$1.81M Buy
313,910
+12,143
+4% +$66.6K 0.26% 84
2016
Q4
$1.48M Buy
301,767
+19,545
+7% +$106K 0.23% 91
2016
Q3
$1.72M Buy
282,222
+96,608
+52% +$578K 0.28% 90
2016
Q2
$1.1M Buy
185,614
+27,133
+17% +$146K 0.19% 92
2016
Q1
$821K Hold
158,481
0.15% 96
2015
Q4
$707K Buy
158,481
+27,175
+21% +$133K 0.13% 98
2015
Q3
$643K Buy
131,306
+95,813
+270% +$520K 0.11% 92
2015
Q2
$217K Buy
+35,493
New +$219K 0.03% 111

Other funds holding ABEV

NS Partners's ABEV Position: Q3 2018 in Review

NS Partners sold out of Ambev (ABEV) in Q3 2018, closing a stake of 492,173 shares — an estimated $2.28M sold.

NS Partners first reported a position in ABEV in Q2 2015 and held it in 13 quarters. The position peaked at $3.49M in Q1 2018. 330 funds tracked by Wall St. Rank hold ABEV as of Q3 2018.

  • NS Partners reported no remaining Ambev position as of Q3 2018 after selling out during the quarter.
  • NS Partners sold 492,173 Ambev shares in Q3 2018, an estimated $2.28M.
  • NS Partners first reported a position in Ambev in Q2 2015 and held it in 13 quarters.
  • NS Partners's Ambev position peaked at $3.49M in Q1 2018.
  • 330 funds tracked by Wall St. Rank held Ambev as of Q3 2018.

Based on NS Partners's 13F filing for Q3 2018, filed 14 Nov 2018.